Relmada Therapeutics is one of the clinical stage companies that develop therapies for dealing with chronic pain. The company is very popular in the country, and not long ago, it had to go to court to deal with a problem it had been experiencing. The US District Court of Nevada issued an associate injunction and a restraining order that was intended to enjoin Laidlaw and its two principles from disseminating misleading information or proxy materials from the company. James Ahern and Mathew Eitner are the two principles of the company, and they received the court orders too.
The U.S District Court issued the restraining order to the Laidlaw & Company after a strong case was filed by Relmada Therapeutics. Laidlaw Company and its two principles had been disseminating information and materials that the court proved that it were false and misleading at the same time. Laidlaw and its principles were doing this to control Relmada Therapeutics.
Laidlaw Company is one of the brokerage companies in the United States. Several years ago, Laidlaw was working as the investment banker for Relmada Therapeutics. Laidlaw has had similar court cases in the past. The brokerage company has found itself in court over several cases from its clients. Several years ago, Laidlaw and its principles were caught trying to violate some financial regulations. Several cases were presented in court by different clients. The company has also received numerous customer complaints, regulatory sanctions and monetary penalties. The reputation of the company is always at stake when the clients take their cases to court.
Sergio Treaversa, the current Chief Executive Officer and president of Relmada Therapeutics told the press that his company was very excited that the court had agreed the restraining order. This clearly proved that the law was on their side. The restraining order would put Laidlaw and its principles in their place.